Searchable abstracts of presentations at key conferences in endocrinology

ea0026p191 | Pituitary | ECE2011

The treatment with dopamine agonists are not associated with increased prevalence of cardiac-valve regurgitation in patients with prolactinomas and acromegalia

Puma M , Lecumberri B , Fernandez A , Dominguez F , Martin M , Yanguela M , Pallardo L , Alvarez C

Background: Dopamine agonists are first-line agents for the treatment of prolactinomas and sometimes are used in patients with acromegalia. There is evidence that these drugs, especially cabergoline, are associated with an increased risk of new cardiac valve regurgitation in patients treated for Parkinson’s disease.Objective: Our objective was to evaluate the prevalence of cardiac valve regurgitation in patients with prolactinomas and acromegalia tr...

ea0056p762 | Neuroendocrinology | ECE2018

A case of impaired vision after cabergoline therapy of macroprolactinoma: case report

Delgado M , Jauregui N , Saenz S , Paz J , Alvarez L , Quintana O , Rojas Marialejandra Delgado , Ibarra Jose Luis Paz

Case report: A male 30 years old, presented with a 12-month history of retro-orbital and frontal headache, oppressive type of moderate intensity, which subsides with analgesics. Subsequently, deterioration of bilateral visual fields, predominantly left side, after that was investigated by a neurologist in INCN in January 2013. A magnetic resonance imaginig scan of the brain showed a 45×50 mm pituitary macroadenoma, with suprasellar extension bowing the optic chiasm and ca...